Inhibrx, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Inhibrx, Inc.
CIK #0001739614
EDGAR Form CIK 2011 - 2025
10-K [0001739614]
10-Q [0001739614]
3 [0001739614]
4 [0001739614]
8-K [0001739614]
D [0001739614]
SC 13G [0001739614]
Form 13D/13G Filer Form 13D/13G Subject Filed
State Street Corp Inhibrx Inc [2023-02-08]
BlackRock Inc Inhibrx Inc [2023-02-03]
RA Capital Management LP Inhibrx Inc [2022-10-17]
Perceptive Advisors LLC Inhibrx Inc [2022-07-19]
RA Capital Management LP Inhibrx Inc [2021-02-16]
Kayyem Jon Faiz Inhibrx Inc [2021-02-12]
Eckelman Brendan P Inhibrx Inc [2021-02-12]
Deveraux Quinn L Inhibrx Inc [2021-02-12]
Lappe Mark Inhibrx Inc [2021-02-12]
LAV Summit Ltd Inhibrx Inc [2021-02-09]
View All
Form 3/4/5 Subject 2011 - 2025
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Parent GP LLC
Halvorsen Ole Andreas
Inhibrx, Inc.
Ott David C.
Shabet Rose Sharon
Viking Global Opportunities GP LLC
Viking Global Investors LP
Inhibrx Biosciences, Inc.
View All
Terms | Privacy | Guide
tony@aum13f.com